NCT03539627View on ClinicalTrials.gov

Azilsartan Medoxomil in Hypertensive pAtients With Stable Ischemic Heart Disease and DiabEtes MEllitus.

CompletedOBSERVATIONAL

Enrollment

184

Participants

Timeline

Start Date

November 7, 2018

Primary Completion Date

April 29, 2022

Study Completion Date

April 29, 2022

Conditions

Arterial HypertensionDiabetes MellitusStable Chronic Angina

Interventions

DRUG

Azilsartan Medoxomil 40 MG Oral Tablet [Edarbi]

patients are to receive azilsartan medoxomil

Trial Locations (1)

650002

Anastasia Kochergina, Kemerovo

All Listed Sponsors

lead

Research Institute for Complex Problems of Cardiovascular Diseases, Russia

OTHER

NCT03539627 - Azilsartan Medoxomil in Hypertensive pAtients With Stable Ischemic Heart Disease and DiabEtes MEllitus. | Biotech Hunter | Biotech Hunter